Skip to main content
SpringerLink
Log in

Prevention of Nitrate Tolerance with Angiotensin II Receptor Type 1 Blocker in Patients with Stable Angina: Yet Another Failed Strategy to Prevent Tolerance

  • Editorial
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brunton TL. Use of Nitrate of Amyl in Angina Pectoris. Lancet 1987;2:628–629.

    Google Scholar 

  2. Goldstein RE, Rosing DR, Redwood DR, et al. Clinical and Circulatory effects of Isosorbide Dinitrate: Comparison with Nitroglycerin. Circulation 1971;43:629–640.

    PubMed  CAS  Google Scholar 

  3. Thadani U, Parker JO. Influence of Glyceryl Trinitrate During Supine and Upright Exercise in Patients with Angina Pectoris. Br Heart J 1978;40:1229–1236.

    PubMed  CAS  Google Scholar 

  4. Thadani U, Fung HL, Darke AC, Parker JO. Oral Isosorbide Dinitrate In Angina Pectoris: Comparison Of Duration Of Action And Dose-Response Relationship And Duration Of Action During Acute Therapy. Circulation 1980;62:491–502.

    PubMed  CAS  Google Scholar 

  5. Thadani U, Manyari D, Parker JO, Fung HL. Tolerance To The Circulatory Effects Of Oral Isosorbide Dinitrate: Rate of Development And Cross Tolerance To Glyceryl Trinitrate. Circulation 1980b;61:526–535.

    CAS  Google Scholar 

  6. Thadani U, Fung HL, Karke AC, Parker JO. Oral Isosorbide Dinitrate In Angina Pectoris: Comparison Of Duration Of Action And Dose-Response Relation During Acute And Sustained Therapy. Am J Cardiol 1982;49:411–419.

    PubMed  CAS  Google Scholar 

  7. Parker JO, Jung HL. Transdermal Nitroglycerin In Angina Pectoris. Am J Cardiol 1984;54:471–476.

    PubMed  CAS  Google Scholar 

  8. Thadani U, Hamilton SF, Olson E, et al. Transdermal Nitroglycerin Patches In Angina Pectoris. Annals of Internal Medicine 1986;105:485–492.

    PubMed  CAS  Google Scholar 

  9. Steering Committee, Transdermal Nitroglycerin Cooperative Study. Acute and Chronic Antianginal Efficacy of Continuous Twenty-Four Hour Application of Transdermal Nitroglycerin. Am J Cardiol 1991;68:1263–1273.

    Google Scholar 

  10. Parker JO, Farrell B, Lahey KA, Moe G. Effect of Intervals Between Doses On The Development Of Tolerance To Isosorbide Dinitrate. N Eng J Med 1987;316:1440–1444.

    Article  CAS  Google Scholar 

  11. Thadani U, Hamilton SF, Olson E, et al. Duration Of Effects And Tolerance Of Slow Release Isosorbide-5-Mononitrate For Angina Pectoris. Am J Cardiol 1987a;59:756–762.

    CAS  Google Scholar 

  12. Thadani U, Prasad R, Hamilton SF, et al. Usefulness Of Twice Daily Isosorbide-5-Mononitrate In Preventing Development Of Tolerance In Angina Pectoris. Am J Cardiol 1987c;60:477–482.

    CAS  Google Scholar 

  13. Zimrin D, Reichek N, Bogin K, et al. Antianginal Effects Of Intavenous Nitroglycerin. Circulation 1988;77:1376–1384.

    PubMed  CAS  Google Scholar 

  14. Cowan JC, Bourke JP, Reid DS. Prevention of Tolerance to Nitroglycerin Patches by Overnight Removal. Am J Cardiol 1987;60:271–275.

    PubMed  CAS  Google Scholar 

  15. DeMots H, Glasser SP. Intermittent Transdermal Nitroglycerin Therapy In The Treatment Of Chronic Stable Angina. J Am Coll Cardiol 1989;13:786–795.

    PubMed  CAS  Google Scholar 

  16. Thadani U, Lipicky RJ. Short And Long Acting Oral Nitrates For Stable Angina Pectoris. Cardiovasc Drugs Ther 1994;8:611–623.

    PubMed  CAS  Google Scholar 

  17. Thadani U, Lipicky RJ. Ointments And Transdermal Nitroglycerin Patches For Stable Angina Pectoris. Cardiovasc Drugs Ther 1994;8:625–633.

    PubMed  CAS  Google Scholar 

  18. Thadani U. Treatment Of Stable Angina. Curr Opin Cardiol 1999;14:349–358.

    PubMed  CAS  Google Scholar 

  19. Thadani U. Nitrate Tolerance, Rebound And Their Clinical Relevance In Stable Angina Pectoris, Unstable Angina And Heart Failure. Cardiovasc Drugs Ther 1996;10:735–742.

    Google Scholar 

  20. Parker JO, Van Koughnott KA, Fung HL. Transdermal Isosorbide Dinitrate in Angina Pectoris. Am J Coll Cardiol 1984;54:8–13.

    CAS  Google Scholar 

  21. Kowaluk E, Hough K, Fung H-L. Effect of Intermittent Exposure and Drug-Free Intervals in the in-vitro vascular Tolerance to Nitroglycerin. Life Sci 1989;44:1157–1163.

    PubMed  CAS  Google Scholar 

  22. Crandall LA, Leak CD, Loventhart AS, et al. Acquired tolerance to and cross tolerance between the nitric acid esters and sodium nitrite in man. J Pharmacol Experimental Ther 1931;41:103–119.

    CAS  Google Scholar 

  23. Ignarro LJ, Lippton H, Edwards JE, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiole as active intermediates. J Pharmacol Experimental Ther 1981;218:739–748.

    CAS  Google Scholar 

  24. Needleman P, Johnson EM Jr. Mechanism of tolerance development to organic nitrates. Pharmacology and Experimental Therapeutics 1973;184:709–715.

    CAS  Google Scholar 

  25. Dupuis J, Lalonde G, Lemieux R, et al. Tolerance to Intravenous Nitroglycerin in Patients with Congestive Heart Failure: Role of Increased Intravascular Volume, Neurohumoral Activation and Lack of Prevention with N-acetylcysteine. J Am Coll Cardiol 1990;16:923–931.

    Article  PubMed  CAS  Google Scholar 

  26. Chen Z, Zhang J, Stamier JS. Identification of the enzymatic mechanism of nitroglycerin bioactivation. PNAS 2002;99(12):8306–1311.

    PubMed  CAS  Google Scholar 

  27. Parker JD, Farrell B, Fenton T, et al. Counter-Regulatory Responses to Continuous and Intermittent Therapy with Nitroglycerin. Circulation 1991;84:2336–2345.

    PubMed  CAS  Google Scholar 

  28. Sage PR, de la Lande IS, Stafford I, et al. Nitroglycerin Tolerance in Human Vessels: Evidence for Impaired Nitroglycerin Bioconversion. Circulation 2000;102:2810–2815.

    PubMed  CAS  Google Scholar 

  29. Wang EQ, Lee WI, Brazeau D, et al. cDNA Microarray Analysis of Vascular Gene Expression After Nitric Oxide Donor Infusion s in Rats: Implications for Nitrate Tolerance Mechanisms. AAPS Pharm Sci 2002;4(2):1–11.

    Google Scholar 

  30. Frame MD, Fox RJ, Kim D, et al. Diminished Arteriolar Responses in nitrate tolerance involve ROS and angiotensin II. Am J Physiol Heart Circ Physiol 2202;282:H2377–H2385.

  31. Munzel T, Giaid A, Kurz S, et al. Evidence For A Role Of Endothelin 1 And Kinase C In Nitroglycerin Tolerance. Proc Natl Acad Sci USA 1995;92:5244–5248.

    PubMed  CAS  Google Scholar 

  32. Kurz S, Hink U, Nickenig G, et al. Evidence for a Causal Role of the Renin-Angiotensin System in Nitrate Tolerance. Circulation 1999:99(24);3181–3187.

    PubMed  CAS  Google Scholar 

  33. Loscalzo J. Folate and Nitrate-Induced Endothelial Dysfunction: A Simple Treatment for a Complex Pathobiology. Circulation 2001;1004:1086–1088.

    Google Scholar 

  34. Munzel T, Mulsch A, Kleschyov A. Mechanisms Underlying Nitroglycerin-Induced Superoxide Production in Platelets: Some Insight, More Questions. Circulation 2002;106:170–172.

    PubMed  Google Scholar 

  35. Munzel T, Sayegh H, Freeman B, et al. Evidence for Enhanced Vascular Superoxide Anion Production in Nitrate Tolerance: A Novel Mechanism Underlying Tolerance and Cross-Tolerance. J Clin Invest 1995;95:187–194.

    Article  PubMed  CAS  Google Scholar 

  36. Gori T, Parker JD. Nitrate tolerance: A Unifying Hypothesis. Circulation 2002;106:2510–2513.

    PubMed  Google Scholar 

  37. Katz R, Levy WS, Buff L, et al. Prevention of Nitrate Tolerance with Angiotension Converting Enzyme Inhibitors. Circulation 1991;83:1271–1277.

    PubMed  CAS  Google Scholar 

  38. Munzel T, Bassenge E. Long-term Angiotensin-Converting Enzyme Inhibition with High-Dose Enalapril Retards Nitrate Tolerance in Large Epicardial Arteries and Prevents Rebound Coronary Vasoconstriction in vivo. Circulation 93(11);1996:2052–2058.

    Google Scholar 

  39. Dakak N, Makhoul N, Flugelman MY, et al. Failure of Captopril to Prevent Nitrate Tolerance in Congestive Heart Failure Secondary to Coronary Artery Disease. Am J Cardiol 1990;66:608–613.

    PubMed  CAS  Google Scholar 

  40. Parker JD, Parker JO. Effect of Therapy With an Angiotensin-Converting Enzyme Inhibitor on Hemodynamic and Counterregulatory Responses During Continuous Therapy with Nitroglycerin. J Am Coll Cardiol 1993;21:1445–1453.

    Article  PubMed  CAS  Google Scholar 

  41. Harai N, Kawano H, Yasue H, et al. Attenuation of Nitrate Tolerance and Oxidative Stress by an Angiotensin II Receptor Blocker in Patients with Coronary Spastic Angina. Circulation 2003;108:1446–1450.

    Google Scholar 

  42. Cotter G, Metzkor-Cotter E, Kaluski E, et al. Usefulness of Losartan, Captopril, and Furosemide in Preventing Nitrate Tolerance and Improving Control of Unstable Angina Pectoris. Am J Cardiol 1998;82:1024–1029.

    PubMed  CAS  Google Scholar 

  43. Milone SD, Azevedo ER, Forster C, et al. The angiotensin II-Receptor Antagonist Losartan Does Not Prevent Hemodynamic or Vascular Tolerance to Nitroglycerin. J Cardiovasc Pharmacol 1999;34(5):645–650.

    PubMed  CAS  Google Scholar 

  44. Longobardi G, Ferrara N, Leosco D, et al. Angiotensin II-Receptor Antagonist Losartan Does Not Preventg Nitroglycerin Tolerance in Patients with Coronary Artery Disease. Cardiovasc Drugs Ther 2004;18:363–370.

    PubMed  CAS  Google Scholar 

  45. Gori T, Burstein JM, Ahmed S, et al. Folic Acid Prevents Nitroglycerin-Induced Nitric Oxide Synthase Dysfunction and Nitrate Tolerance: A Human In Vivo Study. Circulation 2001;104:1119–1123.

    PubMed  CAS  Google Scholar 

  46. McVeigh GE, Hamilton P, Wilson M, et al. Platelet Nitric Oxide and Superoxide Release During the Development of Nitrate Tolerance: Effect of Supplemental Ascorbate. Curculation 2002;106:208–213.

    CAS  Google Scholar 

  47. Hideki W, Masaaki K, Sadanori O, et al. Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Vitamin E on Attenuation of the Development of Nitrate Tolerance. Circulation 1997;96(8):2545–2550.

    Google Scholar 

  48. Parker JO, Parker JD, Caldwell RW, et al. The Effect of Supplemental L-Arginine on Tolerance Development During Continuous Transdermal Nitroglycerin Therapy. J Am Coll Cardiol 2002;2002:1199–1203.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA

    Udho Thadani MD (Professor of Medicine)

Authors
  1. Udho Thadani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Udho Thadani MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thadani, U. Prevention of Nitrate Tolerance with Angiotensin II Receptor Type 1 Blocker in Patients with Stable Angina: Yet Another Failed Strategy to Prevent Tolerance. Cardiovasc Drugs Ther 18, 339–342 (2004). https://doi.org/10.1007/s10557-005-5056-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-005-5056-x

Search

Navigation